Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Differentiated therapy for intraductal papillary mucinous neoplasms].

Literature DB >> 19082569

[Differentiated therapy for intraductal papillary mucinous neoplasms].

M N Wente¹, B M Schmied, J Schmidt, M W Büchler.

Abstract

Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are of increasing interest in the field of pancreatic surgery ever since their first description as an individual pancreatic tumor entity in 1982. The decision for surgical or conservative management is based on the adenoma-carcinoma sequence and the differentiation into main-duct or branch-duct IPMN. Invasive IPMN forms (carcinoma in situ and invasive carcinoma) and in particular noninvasive IPMNs (adenoma and borderline tumors) reveal significantly better survival rates than ductal adenocarcinoma of the pancreas.

Entities: Disease

Mesh：

Year: 2009 PMID： 19082569 DOI： 10.1007/s00104-008-1579-6

Source DB: PubMed Journal: Chirurg ISSN： 0009-4722 Impact factor: 0.955

46 in total

Review 1. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?

Authors: Claudio Bassi; Stefano Crippa; Roberto Salvia
Journal: Gut Date: 2008-03 Impact factor: 23.059

2. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors: Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal: Gastroenterology Date: 2002-11 Impact factor: 22.682

3. Intraductal papillary mucinous tumors of the pancreas.

Authors: T Nakagohri; T Kenmochi; O Kainuma; Y Tokoro; T Asano
Journal: Am J Surg Date: 1999-10 Impact factor: 2.565

4. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors: F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal: Gut Date: 2002-11 Impact factor: 23.059

5. Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Authors: Marco Niedergethmann; Robert Grützmann; Ralf Hildenbrand; Dag Dittert; Niloufar Aramin; Melanie Franz; Frank Dobrowolski; Stefan Post; Hans-Detlev Saeger
Journal: World J Surg Date: 2008-10 Impact factor: 3.352

Review 6. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors: Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal: Am J Surg Pathol Date: 2004-08 Impact factor: 6.394

Review 7. Pancreatic cystic tumors.

Authors: R Salvia; L Festa; G Butturini; A Tonsi; N Sartori; C Biasutti; P Capelli; P Pederzoli
Journal: Minerva Chir Date: 2004-04 Impact factor: 1.000

8. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT.

Authors: Hiroshi Ogawa; Shigeki Itoh; Mitsuru Ikeda; Kojiro Suzuki; Shinji Naganawa
Journal: Radiology Date: 2008-07-15 Impact factor: 11.105

[Differentiated therapy for intraductal papillary mucinous neoplasms].

Review 1. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?

2. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

3. Intraductal papillary mucinous tumors of the pancreas.

4. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

5. Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Review 6. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Review 7. Pancreatic cystic tumors.

8. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT.

9. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

10. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

1. Total pancreatectomy for pancreatic cancer: indications and operative technique.

2. Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.

3. Predictive value of serum carbohydrate antigen 19-9 in malignant intraductal papillary mucinous neoplasms.